Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FRDCB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,708
Award facts
- Contract value 100% obligated
- $24,707.99 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pens with a ceiling value of $24,707.99 under a firm fixed-price contract type. The award was issued on August 28, 2025, with an ultimate completion date of August 29, 2025, and represents a non-competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Dupixent is a biologic immunosuppressant medication commonly prescribed for moderate-to-severe atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps, making this order part of the agency's pharmaceutical supply chain for military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp's consistent receipt of competitive federal contract awards and its capacity to manage both small-value and substantial orders—ranging from under $100 to over $45,000—demonstrates its critical role as a primary pharmaceutical distributor for federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FRDCB?
SPE2DB25FRDCB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 28, 2025.
How much is contract SPE2DB25FRDCB worth?
The government has obligated $24,708 on SPE2DB25FRDCB.
Is contract SPE2DB25FRDCB an order under another contract?
Yes. SPE2DB25FRDCB is a delivery order under SPE2DB25D3008, an indefinite delivery contract.
Was contract SPE2DB25FRDCB competed?
The extent of competition for SPE2DB25FRDCB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award